Add These Dividend Stocks To Your Portfolio To Boost Your Retirement Income, Plus 2 High-Yield Alternatives [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
High-quality, low-risk dividend stocks offer a solid income stream while cushioning your portfolio from inflation. The best dividend stocks for retirement should have a long history of paying steady, increasing dividends, even in market downturns. Wall Street analysts have given favorable ratings to these top dividend stocks for retirement income. Plus, check out two alternative high-yield investment options to add significant income to your retirement portfolio. AbbVie Inc. (NYSE: ABBV ), an American pharmaceutical company, boasts a strong balance sheet backed by $4.0 billion in cash flows from operations and a moderate net debt to EBITDA ratio. With a large market cap of $290.59 billion, AbbVie has increased its dividend by more than 285% since spinning off from Abbott Laboratories in 2013. The stock is a member of the S&P Dividend Aristocrats Index and offers an annual dividend yield of 3.77%, making it a great bet for retirees seeking stability and high dividend yields. Vis
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- AbbVie Recommends Shareholders Reject Tutanota's "Mini-Tender" OfferPR Newswire
- AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate [Yahoo! Finance]Yahoo! Finance
- AbbVie and FutureGen link on inflammatory bowel disease [Yahoo! Finance]Yahoo! Finance
- BioLoomics Appoints Kurt Gish as Chief Scientific Officer to Advance Development of Improved ADCs [Yahoo! Finance]Yahoo! Finance
- Here's How Many Shares Of AbbVie You Would Need To Earn $500 Per Month In Dividends [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 4/26/24 - Miss
ABBV
Sec Filings
- 6/3/24 - Form 25-NSE
- 5/31/24 - Form SD
- 5/17/24 - Form 25-NSE
- ABBV's page on the SEC website